Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2026-05-21 19:21:01 ET · period of report 2026-05-21 · accession 0001123343-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-21 19:21 | 2026-05-21 | NBIX | LYONS GARY A | Dir | M - OptEx | $0.00 | +1,659 | 122.1K | +1% | $0 |
| D | 2026-05-21 19:21 | 2026-05-21 | NBIX | LYONS GARY A | Dir | M - OptEx | $0.00 | -1,659 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | M | A | 1,659 | $0.00 | 122,141 | D | — | — | (F1) 116,158 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power |
| 2 | Derivative | Restricted Stock Unit | 2026-05-21 | M | D | 1,659 | $0.00 | 0 | D | $0.00 · — to — | 1,659 Common Stock | (F2) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. (F3) This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested. (F3) This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested. |